Nancy Dicristo is a seasoned life sciences executive with experience spanning operational and commercial leadership roles. She began her career on the sponsor side at Schering Plough and Celgene Corporation, supporting global clinical trials through commercialization. This foundation shaped her expertise in protocol feasibility, programmatic and site level budgeting, and forecasting complexity at scale.
Nancy later transitioned to the vendor space, partnering with CROs and AROs to support clinical and commercial strategy. At IQVIA, she currently leads global CRO and ARO clinical technology sales and strategy, including the Clinical Trial Financial Suite and site and patient technology solutions.